Cocrystal Pharma Inc (NAS:COCP)
$ 2.41 -0.11 (-4.37%) Market Cap: 25.64 Mil Enterprise Value: 14.49 Mil PE Ratio: 0 PB Ratio: 2.02 GF Score: 37/100

Cocrystal Pharma Inc at LD Micro Main Event Transcript

Oct 26, 2022 / 10:30PM GMT
Release Date Price: $2.17 (+0.93%)
Unidentified Participant

All right, everyone. Welcome. Today, I'm happy to introduce to you Sam Lee, President and Interim CEO of Cocrystal Pharma. Come take it away, Sam.

Sam Lee
Cocrystal Pharma, Inc. - Interim Co-CEO and President

Good afternoon, everyone. I'm very delighted to be here -- LD Micro to share our progress with you. Cocrystal Pharma is an antiviral therapeutic company. During my presentation, I will be talking about the forward-looking statements. If you have any questions, please visit our website.

Cocrystal Pharma was founded by three scientists, Roger Kornberg, and Gary Wilcox, and myself. Roger Kornberg is a 2006 Nobel Prize winner, and he is at Stanford University. He did pioneer work on structure biology of transcription replication complexes. Based on his work we developed the platform of drug discovery technology.

We now further optimized, and we validated scientifically, commercially this platform approach for developing a broad-spectrum antiviral compound. This technology identifies high valued antiviral drug targets and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot